Immunic Presents Data From Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Ulcerative Colitis at the United European Gastroenterology Week 2023

[ad_1] NEW YORK, Oct. 16, 2023 /PRNewswire/ — Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today…

Immunic Presents Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis at MSMilan2023: The 9th Joint ECTRIMS-ACTRIMS Meeting

[ad_1] – Improvement in Serum Neurofilament Light Chain (NfL) Observed in Both Treatment Arms of Vidofludimus Calcium Over Placebo – – NfL Effect Consistent With Recently Released Data from Separate,…

Biggest Crypto Gainers Today on DEXTools – Calcium, FINE, Tyrion.finance

[ad_1] Source: DEXTools Twitter / DEXTools Logo The price of Bitcoin has held steady this week even as stocks have tumbled, a divergence that some analysts say could signal more…

Opinion | Proper Nutrition Can Prevent Postpartum Depression

[ad_1] The new drug is a breakthrough, but taking calcium during pregnancy may minimize the need for it. [ad_2] Source link